Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

Behind the Study: Molecular Dialogue Between Tumor Cells and Fibroblasts

Oncotarget

May 25, 2023
Dr. Gopal C. Kundu from KIIT Deemed to be University in Odisha, India, describes a recent editorial he co-authored that was published by Oncotarget in Volume 14, entitled, “The molecular dialogue between the tumor cells and fibroblasts.” continue reading »

HER3: Survival Pathway and Therapeutic Target in Metastatic Colorectal and Pancreatic Cancer

News

May 24, 2023
PRESS RELEASE: On May 10, 2023, a new research perspective was published in Oncotarget, entitled, “HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma.” continue reading »

GPR141 Regulates Breast Cancer Progression via Oncogenic Mediators and The p-mTOR/p53 Axis

News

May 22, 2023
PRESS RELEASE: On May 19, 2023, a new research paper was published in Oncotarget, entitled, “G-protein-coupled receptor 141 mediates breast cancer proliferation and metastasis by regulating oncogenic mediators and the p-mTOR/p53 axis.” continue reading »

Targeting Cellular Respiration as a Therapeutic Strategy in Glioblastoma

News

May 19, 2023
PRESS RELEASE: On May 4, 2023, a new research perspective was published in Oncotarget, entitled, “Targeting cellular respiration as a therapeutic strategy in glioblastoma.” continue reading »

Automated, Accurate Reporting for NGS-Based Clonality Testing

News

May 16, 2023
PRESS RELEASE: On May 12, 2023, a new research paper was published in Oncotarget, entitled, “Development and implementation of an automated and highly accurate reporting process for NGS-based clonality testing.” continue reading »